Athira Pharma, Inc. (41) | Change of Control Agreements (8)

Recent Contracts

Change in Control and Severance Agreement between the Registrant and Kevin Church (Filed With SEC on March 28, 2022)
Amended and Restated Change in Control and Severance Agreement between the Company and Mark Litton, Ph.D (Filed With SEC on January 31, 2022)
Change in Control and Severance Agreement between the Registrant and Rachel Lenington (Filed With SEC on August 16, 2021)
Change in Control and Severance Agreement between the Registrant and Mark Worthington (Filed With SEC on August 16, 2021)
Change in Control and Severance Agreement between the Registrant and Hans Moebius, Ph.D (Filed With SEC on September 14, 2020)
Change in Control and Severance Agreement between the Registrant and Leen Kawas, Ph.D (Filed With SEC on September 9, 2020)
Change in Control and Severance Agreement between the Registrant and Mark Litton, Ph.D (Filed With SEC on September 9, 2020)
Change in Control and Severance Agreement between the Registrant and Glenna Mileson (Filed With SEC on September 9, 2020)